Julie has made over 1 trades of the Amyris Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently she exercised 1,000 units of AMRS stock worth $50 on 12 November 2015.
The largest trade she's ever made was exercising 1,000 units of Amyris Inc stock on 12 November 2015 worth over $50. On average, Julie trades about 167 units every 0 days since 2015. As of 12 November 2015 she still owns at least 14,983 units of Amyris Inc stock.
You can see the complete history of Mrs. Washington stock trades at the bottom of the page.
Julie S. Washington serves as Director of the Company. An accomplished senior executive, Mrs. Washington has led a distinguished career in marketing, spanning leading companies like Champion Petfoods, Procter & Gamble, Gillette, Nestlé Purina, Jamba Juice, and Luxottica. Mrs. Washington currently serves as Chief Marketing & Communication Officer at Trinity Health, a Catholic health care delivery system that serves more than 30 million people across 22 states. Mrs. Washington’s commitment to community improvement, diversity & inclusion has been recognized with a variety of professional accolades; inter alia: selection as one of Black Enterprise’s “Top Women Executives in Advertising & Marketing” (2016, 2013); listing in Savoy Magazine’s Top 100 Most Influential Blacks in Corporate America (2020, 2018, 2010); and naming as one of the “Top B2C Marketing Executive of the Year” (Marketers That Matter, 2013).
Julie Washington is 50, she's been the Director of Amyris Inc since 2020. There are 19 older and 1 younger executives at Amyris Inc. The oldest executive at Amyris Inc is Patrick Yang, 72, who is the Independent Director.
Julie's mailing address filed with the SEC is 6475 Christie Ave #150, Emeryville, CA 94608, USA.
Over the last 14 years, insiders at Amyris Inc have traded over $118,642,007 worth of Amyris Inc stock and bought 100,049,915 units worth $258,812,433 . The most active insiders traders include Gas & Power Usa, Sas Total, L John Doerr, and Philippe Boisseau. On average, Amyris Inc executives and independent directors trade stock every 25 days with the average trade being worth of $65,903. The most recent stock trade was executed by Hermanus Kieftenbeld on 2 June 2023, trading 20,999 units of AMRS stock currently worth $19,949.
amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. the company is delivering its no compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. more information about the company is available at www.amyris.com.
Amyris Inc executives and other stock owners filed with the SEC include: